DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $388,277 | +2.1% | 1,565 | -1.3% | 0.06% | +9.3% |
Q2 2023 | $380,400 | +1.8% | 1,585 | +7.0% | 0.05% | -5.3% |
Q1 2023 | $373,523 | -18.8% | 1,482 | -14.5% | 0.06% | -20.8% |
Q4 2022 | $460,238 | +2.3% | 1,734 | -0.5% | 0.07% | -4.0% |
Q3 2022 | $450,000 | +0.4% | 1,742 | -1.4% | 0.08% | +2.7% |
Q2 2022 | $448,000 | -13.5% | 1,767 | 0.0% | 0.07% | +1.4% |
Q1 2022 | $518,000 | -11.0% | 1,767 | -0.1% | 0.07% | -7.7% |
Q4 2021 | $582,000 | +7.6% | 1,769 | -0.4% | 0.08% | -3.7% |
Q3 2021 | $541,000 | +23.8% | 1,776 | +9.1% | 0.08% | +1.2% |
Q2 2021 | $437,000 | +19.4% | 1,628 | 0.0% | 0.08% | +1.3% |
Q1 2021 | $366,000 | +1.1% | 1,628 | 0.0% | 0.08% | -4.8% |
Q4 2020 | $362,000 | +3.1% | 1,628 | 0.0% | 0.08% | -6.7% |
Q3 2020 | $351,000 | +2.9% | 1,628 | -15.6% | 0.09% | -16.8% |
Q2 2020 | $341,000 | -2.0% | 1,928 | -23.3% | 0.11% | -28.2% |
Q1 2020 | $348,000 | -15.7% | 2,514 | -6.6% | 0.15% | +0.7% |
Q4 2019 | $413,000 | +17.7% | 2,691 | +10.7% | 0.15% | +12.1% |
Q3 2019 | $351,000 | -10.0% | 2,431 | -11.0% | 0.13% | -14.3% |
Q2 2019 | $390,000 | +8.0% | 2,731 | 0.0% | 0.15% | -2.5% |
Q1 2019 | $361,000 | +7.1% | 2,731 | -16.4% | 0.16% | +16.2% |
Q4 2018 | $337,000 | -4.3% | 3,268 | +1.0% | 0.14% | +28.3% |
Q3 2018 | $352,000 | +17.7% | 3,235 | +6.7% | 0.11% | +6.0% |
Q2 2018 | $299,000 | -12.3% | 3,031 | -12.9% | 0.10% | -20.0% |
Q1 2018 | $341,000 | – | 3,480 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |